Video

Dr. Henderson on the Benefits of Proton Therapy in Prostate Cancer

Randal H. Henderson, MD, MBA, professor, Department of Radiation Oncology, associate medical director, University of Florida Health Proton Therapy Institute, discusses the benefits of proton therapy in prostate cancer.

Randal H. Henderson, MD, MBA, professor, Department of Radiation Oncology, associate medical director, University of Florida Health Proton Therapy Institute, discusses the benefits of proton therapy in prostate cancer.

More normal tissue can be spared with proton therapy as compared with traditional intensity-modulated radiation therapy (MRT), says Henderson. Additionally, patients who undergo proton therapy are spared unnecessary doses of radiation to their bladder or rectum and thus, added complications. Notably, rectal complications have been linked with the amount of rectum that is exposed to radiation, adds Henderson.

Two types of injury can occur from radiation therapy; these injuries are dependent on the dosage of radiation received. For example, high doses of radiation can result in rectal bleeding and ulcerations. Both proton therapy and IMRT treat a small area of the anterior rectal wall at high intensity, notes Henderson. However, the 2 approaches diverge in the expanse of the remainder of the rectum treated. Protons completely spare the posterior part of the rectal wall whereas IMRT treats the entire circumference of the rectal wall, explains Henderson.

Related Videos
David A. Braun, MD, PhD
Bradley McGregor, MD,
Francisco J. Hernandez-Ilizaliturri, MD, professor, oncology, Department of Medicine – Lymphoma, director, Lymphoma Research, head, Lymphoma Translational Research Lab, associate professor, Department of Immunology, Roswell Park Comprehensive Cancer Center; clinical professor, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Rahul Banerjee, MD, FACP, assistant professor, Clinical Research Division, Fred Hutchinson Cancer Center; assistant professor, Division of Hematology and Oncology, University of Washington
Monica H. Vetter, MD
Ian Krop MD, PhD
Marco Davila, MD, PhD
Yvonne Mowery, MD, PhD, associate professor, Department of Radiation Oncology, UPMC Hillman Cancer Center/University of Pittsburgh, radiation oncologist, Mary Hillman Jennings Radiation Oncology, UPMC Shadyside
Gustavo Werutsky, MD, PhD, medical oncologist, Breast Cancer Program, Hospital Moinhos de Vento; investigator, Oncology Research Centre, Hospital São Lucas PUCRS University
Ewa Kalinka, MD, PhD